SBFM
Sunshine Biopharma Inc
NASDAQ: SBFM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.96
-0.43% today
Updated 2026-04-30
Market cap
$4.81M
P/E ratio
—
P/S ratio
0.13x
EPS (TTM)
$-1.44
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
Sunshine Biopharma Inc (SBFM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0.00 | $0.00 | $1708.00 | $0.00 | $0.00 | $447200.00 | $21121.00 | $71410.00 | $228426.00 | $4.35M | $24.09M | $34.87M | $36.31M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | -100.0% | — | — | -95.3% | +238.1% | +219.9% | +1802.4% | +454.4% | +44.7% | +4.1% |
| Cost of revenue | — | — | — | — | — | $250000.00 | $475000.00 | $263333.00 | $384581.00 | $60731.00 | $6629.00 | $391081.00 | $11050.00 | $25847.00 | $117830.00 | $2.65M | $15.75M | $24.20M | $24.38M |
| Gross profit | — | — | — | — | — | $-250000.00 | $-475000.00 | $-263333.00 | $1708.00 | $-60731.00 | $-6629.00 | $56119.00 | $10071.00 | $45563.00 | $110596.00 | $1.70M | $8.34M | $10.67M | $11.92M |
| Gross margin | — | — | — | — | — | — | — | — | 100.0% | — | — | 12.5% | 47.7% | 63.8% | 48.4% | 39.0% | 34.6% | 30.6% | 32.8% |
| R&D | — | — | — | — | $142650.00 | $1829.00 | $137400.00 | $327000.00 | $8657.00 | $32793.00 | $0.00 | $12800.00 | $15204.00 | $1728.00 | $672209.00 | $811858.00 | $1.86M | $933902.00 | $604308.00 |
| SG&A | — | $24079.00 | $15631.00 | $537382.00 | $413552.00 | $704851.00 | $1.80M | $1.32M | $769077.00 | $899584.00 | $850561.00 | $1.21M | $622729.00 | $606643.00 | $1.87M | $8.90M | $10.10M | $14.00M | $18.48M |
| Operating income | $-13122.00 | $-26079.00 | $-15651.00 | $-537382.00 | $-556202.00 | $-706680.00 | $-1.94M | $-1.76M | $-780277.00 | $-993108.00 | $-857190.00 | $-1.17M | $-641636.00 | $-576874.00 | $-2.44M | $-8.67M | $-4.79M | $-5.81M | $-4.48M |
| Operating margin | — | — | — | — | — | — | — | — | -45683.7% | — | — | -260.9% | -3037.9% | -807.8% | -1068.2% | -199.6% | -19.9% | -16.7% | -12.3% |
| EBITDA | $-13122.00 | $-26079.00 | $-15651.00 | $-537382.00 | $-556202.00 | $-706680.00 | $-1.94M | $-1.76M | $-1.34M | $-932377.00 | $-928780.00 | $-1.99M | $-948379.00 | $-2.60M | $-12.09M | $-26.45M | $-3.82M | $-5.14M | $-4.15M |
| EBITDA margin | — | — | — | — | — | — | — | — | -78539.0% | — | — | -444.7% | -4490.2% | -3643.6% | -5294.9% | -608.6% | -15.9% | -14.7% | -11.4% |
| EBIT | $-13122.00 | $-26079.00 | $-15651.00 | $-537382.00 | $-556202.00 | $-706680.00 | $-1.94M | $-1.76M | $-1.35M | $-993108.00 | $-935409.00 | $-2.04M | $-962153.00 | $-2.62M | $-12.11M | $-26.47M | $-3.97M | $-5.36M | $-4.48M |
| Interest expense | $13122.00 | $5026.00 | $9364.00 | — | $556202.00 | $1272.00 | $6455.00 | $179096.00 | $307211.00 | $34732.00 | $104829.00 | $159420.00 | $115901.00 | $168105.00 | $328818.00 | $39412.00 | $137308.00 | $8774.00 | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13122.00 | $-31105.00 | $-25015.00 | $-537382.00 | $-556202.00 | $-707952.00 | $-2.49M | $-1.93M | $-1.65M | $-3.50M | $-1.04M | $-2.16M | $-1.66M | $-2.78M | $-12.44M | $-26.74M | $-4.51M | $-5.13M | $-5.98M |
| Net income growth (YoY) | — | -137.0% | +19.6% | -2048.2% | -3.5% | -27.3% | -251.9% | +22.4% | +14.5% | -111.5% | +70.3% | -107.3% | +23.0% | -67.7% | -346.7% | -115.0% | +83.2% | -13.9% | -16.4% |
| Profit margin | — | — | — | — | — | — | — | — | -96774.5% | — | — | -482.1% | -7860.9% | -3898.7% | -5444.4% | -615.4% | -18.7% | -14.7% | -16.5% |